{"name":"Hopen Life Science Ventures","permalink":"hopen-life-science-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/hopen-life-science-ventures","homepage_url":"http://hopenls.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"616-464-5071","description":"","email_address":"info@hopenls.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Oct 17 12:39:11 UTC 2012","updated_at":"Wed Oct 17 12:43:17 UTC 2012","overview":"<p>Hopen Life Science Ventures (www.hopenls.com) is a Midwest-based venture capital firm that invests in exceptional early- to mid-stage life science opportunities. With offices in Michigan and Ohio, the Firm is very active in the Midwest, a geographic region steeped in life science innovation, but traditionally underserved with capital. The Hopen team includes investment professionals with extensive prior experience launching and ramping private and public life science companies. Hopen manages over $65 million of capital and is actively making new investments via Hopen Life Science Fund II.</p>","image":{"available_sizes":[[[150,63],"assets/images/resized/0021/5931/215931v1-max-150x150.jpg"],[[244,104],"assets/images/resized/0021/5931/215931v1-max-250x250.jpg"],[[244,104],"assets/images/resized/0021/5931/215931v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"3133 Orchard Vista Dr SE","address2":"","zip_code":"49546","city":"Grand Rapids","state_code":"MI","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/tolera-therapeutics-closes-series-b-3-financing-raises-55-million-to-submit-phase-3-special-protocol-assessment-for-its-immune-targeting-biologic-drug-in-kidney-transplantation-174443781.html","source_description":"Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation PR Newswire","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":16,"company":{"name":"Tolera Therapeutics","permalink":"tolera-therapeutics","image":{"available_sizes":[[[138,79],"assets/images/resized/0004/5655/45655v1-max-150x150.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-250x250.jpg"],[[138,79],"assets/images/resized/0004/5655/45655v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}